Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 283 Records) |
Query Trace: Myelofibrosis and JAK2[original query] |
---|
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis. Nature communications 2022 Sep 13 (1): 5284. Brown Derek W, Zhou Weiyin, Wang Youjin, Jones Kristine, Luo Wen, Dagnall Casey, Teshome Kedest, Klein Alyssa, Zhang Tongwu, Lin Shu-Hong, Lee Olivia W, Khan Sairah, Vo Jacqueline B, Hutchinson Amy, Liu Jia, Wang Jiahui, Zhu Bin, Hicks Belynda, Martin Andrew St, Spellman Stephen R, Wang Tao, Deeg H Joachim, Gupta Vikas, Lee Stephanie J, Freedman Neal D, Yeager Meredith, Chanock Stephen J, Savage Sharon A, Saber Wael, Gadalla Shahinaz M, Machiela Mitchell |
MPN-354 Characteristics of Patients With Myelofibrosis Taking Ruxolitinib for 3 or More Years. Clinical lymphoma, myeloma & leukemia 2022 9 22 Suppl 2 S334. Masarova Lucia, Bose Prithviraj, Pemmaraju Naveen, Kantarjian Hagop, Estrov Zeev, Verstovsek Srd |
JAK2 rs10974944 is associated with both V617F-positive and negative myeloproliferative neoplasms in a Vietnamese population: A potential genetic marker. Molecular genetics & genomic medicine 2022 Aug e2044. Ngoc Nguyen Thy, Hau Bui Bich, Vuong Nguyen Ba, Xuan Nguyen T |
The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms. Blood cells, molecules & diseases 2022 8 97 102698. Wang Jin, Zhang Jin, Huang Jinjin, Mei Yu, Hong Zhen |
Development of a Real-Time qPCR Assay for Detection of Common MPL Mutations in Myeloproliferative Neoplasms (MPNS). Applied biochemistry and biotechnology 2022 7 194 (12): 5907-5917. Ullah Naeem, Khan Sadiq Noor, Umair Muhammad, Khan Aamir Ali, Liu Xinhui, Khattak Aamer Ali, Yousafzai Yasar Mehmo |
Targeted sequencing of candidate gene regions for myelofibrosis in dogs. Journal of veterinary internal medicine 2022 7 36 (4): 1237-1247. Campbell Amelia G, Seelig Davis M, Beckman Joan D, Minor Katie M, Heinrich Daniel A, Friedenberg Steven G, Modiano Jaime F, Furrow E |
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype. Acta haematologica 2022 11 146 (1): 14-25. Barosi Giovanni, Campanelli Rita, Massa Margherita, Catarsi Paolo, Carolei Adriana, Abbà Carlotta, Villani Laura, Magrini Umberto, Gregato Giuliana, Bertolini Francesco, de Silvestri Annalisa, Gale Robert Peter, Rosti Vittor |
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score. Blood cancer journal 2022 11 12 (11): 156. Barbui Tiziano, Ghirardi Arianna, Carobbio Alessandra, Masciulli Arianna, Carioli Greta, Rambaldi Alessandro, Finazzi Maria Chiara, Bellini Marta, Rumi Elisa, Vanni Daniele, Borsani Oscar, Passamonti Francesco, Mora Barbara, Brociner Marco, Guglielmelli Paola, Paoli Chiara, Alvarez-Larran Alberto, Triguero Ana, Garrote Marta, Pettersson Helna, Andréasson Björn, Barosi Giovanni, Vannucchi Alessandro Mar |
Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms. Diagnostics (Basel, Switzerland) 2022 11 12 (11): . Kim Hyun-Young, Han Yujin, Jang Jun Ho, Jung Chul Won, Kim Sun-Hee, Kim Hee-J |
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 2022 Oct . Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. Frontiers in oncology 2023 9 13 1224590. Patryk Sobieralski, Bartosz Was?g, Aleksandra Leszczy?ska, Monika ?uk, Maria Bieniaszews |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
The Clinical Impact of JAK2V617F allele burden in Philadelphia-negative Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2023 8 . ?pek Yönal-Hindilerden, Ezgi ?ahin, Fehmi Hindilerden, Aynur Da?lar-Aday, Meliha Nalça |
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. Cancers 2023 8 15 (15): . Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francesca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larr |
Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN. Frontiers in genetics 2023 7 14 1198834. Jin Zhang, Kefeng Shen, Min Xiao, Jinjin Huang, Jin Wang, Yaqin Wang, Zhenya Ho |
Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. Molecular biology reports 2023 5 . It?r ?irino?lu Demiriz, Mehmet Hanifi Kazanci, Esra Menfaatli, Davoud Jafari-Gharabaghlou, Nosratollah Zargha |
JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients. Hematology/oncology and stem cell therapy 2023 4 16 (3): 303-314. Shires Karen L, Rust Adriana J, Harryparsad Rushil, Coburn Justin A, Gopie Ruth |
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
Exploration of the role of NKG2D ligands MICA and MICB in JAK2 V617F-positive myeloproliferative neoplasms. HLA 2023 4 . Ivanova Milena, Tsvetkova Gergana, Lessichkova Spaska, Gesheva Nevena, Hadjiev Evgueniy, Shivarov Veliz |
Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016. Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way |
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
JAK2V617F Mutation and Associated Chromosomal Alterations in Primary and Secondary Myelofibrosis and Post-HCT Outcomes. Blood advances 2023 11 . Maryam Rafati, Derek Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadal |
Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil. Biomedical reports 2023 11 19 (6): 98. Dania G Torres, Emanuela V Barbosa Alves, Miliane Araújo de Sousa, Wanessa H Laranjeira, Jhemerson Paes, Erycka Alves, Deborah Canté, Allyson G Costa, Adriana Malheiro, Rosângela Abreu, Leny Nascimento, Nelson A Fraiji, George A V Silva, Lucivana P de Souza Mourão, Andréa M Tarra |
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: